Clinical Trials Directory

Trials / Completed

CompletedNCT01581437

Recording for Potential AF Drivers and Patient Specific Atrial Anatomy & Atrial Electrogram Maps

Recording for Potential AF Drivers and Patient Specific Atrial Anatomy and Atrial Electrogram Maps Using an FDA Approved 64-Pole Basket Catheter (CONFIRM)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The 64 pole basket catheter used for the mapping procedure will be defined "atypical" sites which sustain atrial fibrillation. The ablation through the driver will lead to more rapid ablation of the atrial fibrillation.

Detailed description

Atrial fibrillation (AF) is a common abnormal and rapid heart rhythm characterized by erratic electrical activity of the upper chambers of the heart. This cardiac arrhythmia may lead to stroke, heart failure, low blood pressure, chest pain, and increased mortality rate. Treatment may include medication to stop the rhythm abnormality, blood thinners, and/or ablation. Ablation involves application of heat or freezing to the area sustaining the rhythm abnormality. This requires tubes (catheters)to be placed in the heart. Human atrial fibrillation may be sustained by localized drivers (rapid and/or organized sites of atrial electrical activation). By mapping/recording the patient's specific atrial anatomy and atrial electrical activity with the 64-pole basket catheter, we may add to the knowledge base of these driver locations. We may also add to the knowledge about where best to ablate to terminate the arrhythmia. Typical anatomic

Conditions

Interventions

TypeNameDescription
PROCEDURE64 pole basket catheterThe 64 pole basket catheter expands into a small flexible balloon that conforms to the atrial anatomy.

Timeline

Start date
2011-10-01
Primary completion
2013-12-01
Completion
2013-12-01
First posted
2012-04-20
Last updated
2016-03-11
Results posted
2016-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01581437. Inclusion in this directory is not an endorsement.